Respiratory Health Clinical Trial
— CRESPIOfficial title:
Daycare Environmental Exposure to Cleaning Products and Respiratory Health in Young Children and Daycare Workers
CRESPI - RESPIratory health of Children in daycare
The CRESPI study, will be a cohort of 1500/2000 children attending daycare in Paris region,
and will be initiated in November 2019.
The aim of the project is to study the impact of environmental exposures to cleaning products
and disinfectants on respiratory health of infants and toddlers (< 3 years) in daycares
Two specific aims were defined:
1. evaluate environmental exposure to cleaning products by complementary and innovative
tools: air quality measurements in daycares, specific standardized questionnaire,
identification of compounds of the products via a database and a Smartphone application
to scan bar codes and inform on product use
2. evaluate the impact of early exposure in daycares and at home on respiratory health of
young children
Status | Not yet recruiting |
Enrollment | 2000 |
Est. completion date | December 31, 2023 |
Est. primary completion date | November 19, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 2 Months to 4 Years |
Eligibility |
Inclusion Criteria: Children : - aged from 2 months to 3 years (< 4 years) attending daycares in Paris region, among those which accepted to participate to the CRESPI study - signed and dated written informed consent form obtained from at least one parent Nursery workers : - all those who accepted to participate - signed and dated written informed consent form obtained Exclusion Criteria: Children and workers : if it is impossible for them (parents or workers) to understand French langage and/or to follow the questionnaire of the study Children - both parents less than 18 years old - parents subjected to a legal protection measure or deprived of liberty by judicial or administrative decision - if at least two children of the same familly attended the same daycare, only the youngest one will be included. In case of twins or triplets, only one children will be chosen at random. |
Country | Name | City | State |
---|---|---|---|
France | Nicole LE MOUAL | Villejuif |
Lead Sponsor | Collaborator |
---|---|
Institut National de la Santé Et de la Recherche Médicale, France | ADEME, Agence Regionale de Sante d'Ile de France, ANSES, Centre Scientifique et Technique du Bâtiment, Ecole des Hautes Etudes en Santé Publique, EPICONCEPT, Fondation de France, National Research Agency, France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Current wheezing | 'Current wheezing' phenotypes will be defined by questionnaires (paper, smartphone, web), based on responses to epidemiological standardized questionnaires and in accordance with definitions used in international studies: wheezing in the last 12 months severe wheezing in the last 12 months (defined by wheezing in the last 12 months with use of inhaled corticosteroid and/or the need for hospital-based care [emergency department visit and/or hospitalization due to bronchiolitis wheezy bronchitis or asthma attacks] in the last 12 months) recurrent wheezing (at least 3 wheezing episodes in the last 12 months). |
at inclusion (2019-2021) | |
Primary | Longitudinal wheezing | Longitudinal wheezing phenotypes will be defined by longitudinal latent class analysis (statistical clustering approach), making full use of data collected by questionnaire during follow-up (first monthly and then every six months), from infancy to age 4-years. | at inclusion (2019-2021), every month by a smartphone application (during 1 year after inclusion), every 6 months by questionnaires (2021 to 2023) | |
Secondary | Current cough | Cough in the last 12 months defined by a standardised questionnaire will also be examined. | at inclusion (2019-2021) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04758845 -
Clinical Study to Evaluate the Safety and Efficacy of New Probiotic Strains in Health Adults
|
N/A | |
Recruiting |
NCT04812561 -
Effects of Bronch™ on Respiratory Health
|
N/A | |
Completed |
NCT04368169 -
The Effects of an Aromatic Botanical Extract on Respiratory Health.
|
N/A |